https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
Ahead of the curve — he practically lives there. Before most of the world had even asked ChatGPT its first question, Elad Gil was writing early checks into companies like Perplexity, Character.AI, and Harvey. That’s just a slice of his story. His track record spans seed and Series A investments in over 30 unicorns and … Read more
Elad Gil isn’t just ahead of the curve — he practically lives there. Before most of the world had even asked ChatGPT its first question, Gil was writing early checks into companies like Perplexity, Character.AI, and Harvey. And that’s just a slice of the story. His track record includes seed or Series A investments in … Read more
Vlad Matsiiako is in the business of secrets. “If secrets aren’t there, then it’s just not possible for software to run,” said Matsiiako, CEO and cofounder of Infisical. “Databases can’t connect to each other. Developers can’t use any resources. AI agents can’t integrate with the whole ecosystem. Basically, secrets are the glue that connects everything. … Read more
Elad Gil started betting on AI before most of the world took notice. By the time investors began grasping the implications of ChatGPT, Gil had already written seed checks to startups like Perplexity, Character.AI, and Harvey. Now, as the early winners of the AI wave become clearer, the renowned “solo” VC is increasingly focused on … Read more
Abridge, a healthcare AI startup, recently raised a $250 million Series D, Fortune has exclusively confirmed. Read More
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4